Mette Rosenkilde

Mette Rosenkilde

Professor

Member of:

    ORCID: 0000-0001-9600-3254

    Publication year:
    All
    1 - 4 out of 4Page size: 50
    1. 2024
    2. Published

      GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology

      Rosenkilde, Mette, Lindquist, Peter, Kizilkaya, Hüsün Sheyma & Gasbjerg, Lærke Smidt, 1 Apr 2024, In: Peptides. p. 171212

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Advances in incretin-based therapeutics for obesity

      Rosenkilde, Mette, 2024, In: Nature Reviews Endocrinology. 20, p. 67–68 2 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Accepted/In press

      Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes

      Skov-Jeppesen, Kirsa, Christiansen, Charlotte Bayer, Hansen, L. S., Windeløv, Johanne Agerlin, Hedbäck, N., Gasbjerg, Lærke Smidt, Hindsø, M., Svane, M. S., Madsbad, Sten, Holst, Jens Juul, Rosenkilde, Mette & Hartmann, Bolette, 2024, (Accepted/In press) In: The Journal of clinical endocrinology and metabolism.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity

      Dillemans, L., Yu, K., De Zutter, A., Noppen, S., Gouwy, M., Berghmans, N., Verhallen, L., De Bondt, M., Vanbrabant, L., Brusselmans, S., Martens, E., Schols, D., Verschueren, P., Rosenkilde, Mette, Marques, P. E., Struyf, S. & Proost, P., 2024, In: Cell Communication and Signaling. 22, 1, 23 p., 94.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3361